Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center

Yokoyama, S; Honda, T; Ishizu, Y; Imai, N; Ito, T; Yamamoto, K; Mizuno, K; Kojima, T; Kariya, N; Nakamura, M; Kawashima, H

CLINICAL NUTRITION   Vol. 43 ( 6 ) page： 1425 - 1432   2024.6

Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma

Inukai, Y; Yamamoto, K; Honda, T; Yokoyama, S; Ito, T; Imai, N; Ishizu, Y; Nakamura, M; Ishigami, M; Kawashima, H

CANCERS   Vol. 16 ( 9 )   2024.5

Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team

Ito, T; Mizuno, K; Yamamoto, T; Yasuda, T; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Hama, M; Kataoka, T; Shimokata, T; Ando, Y; Kawashima, H

HEPATOLOGY RESEARCH     2024.4

Evaluation of 4D Flow MRI-Derived Relative Residence Time as a Marker for Cirrhosis Associated Portal Vein Thrombosis

Hyodo, R; Takehara, Y; Ishizu, Y; Nishida, K; Mizuno, T; Ichikawa, K; Horiguchi, R; Kurata, N; Ogura, Y; Yokoyama, S; Naganawa, S; Jin, N; Ichiba, Y

JOURNAL OF MAGNETIC RESONANCE IMAGING     2024.3

Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease

Yamamoto, K; Honda, T; Inukai, Y; Yokoyama, S; Ito, T; Imai, N; Ishizu, Y; Nakamura, M; Kawashima, H

MICROORGANISMS   Vol. 12 ( 3 )   2024.3

A 70-year-old Woman with Asymptomatic Ferroportin Disease.

Ishikawa T, Tatsumi Y, Kato K, Hayashi Y, Imai N, Ito T, Ishizu Y, Ishigami M, Nihei W, Kato A, Hayashi H

Internal medicine (Tokyo, Japan)     2024.2

A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria

Yokoyama, S; Ishizu, Y; Honda, T; Imai, N; Ito, T; Yamamoto, K; Muto, H; Shirota, C; Tainaka, T; Sumida, W; Makita, S; Takada, S; Nakagawa, Y; Maeda, T; Nakamura, M; Ishigami, M; Uchida, H; Kawashima, H

HEPATOLOGY RESEARCH     2023.10

Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia.

Matsuda N, Imai N, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Kawashima H

European journal of gastroenterology & hepatology   Vol. 35 ( 10 ) page： 1211 - 1215   2023.10

Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis.

Uchida G, Nakamura M, Yamamura T, Maeda K, Sawada T, Ishikawa E, Furukawa K, Iida T, Mizutani Y, Yamao K, Ishikawa T, Ishizu Y, Honda T, Ishigami M, Kawashima H

Inflammatory intestinal diseases   Vol. 8 ( 2 ) page： 60 - 68   2023.10

Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis.

Sugiyama Y, Yamamoto K, Honda T, Kato A, Muto H, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Asano T, Enomoto A, Zaitsu K, Ishigami M, Fujishiro M, Kawashima H

Hepatology international     2023.9

Significance of pretreatment alpha-fetoprotein in patients with compensated severe fibrosis after hepatitis C viral eradication

Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Kawashima Hiroki

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   Vol. 30 ( 6 ) page： 834 - 842   2023.6

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis

Yamamoto Takafumi, Mizuno Kazuyuki, Ito Takanori, Yokoyama Shinya, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Ishikawa Takuya, Kanamori Akira, Yasuda Satoshi, Toyoda Hidenori, Yokota Kenji, Hase Tetsunari, Nishio Naoki, Maeda Osamu, Ishii Makoto, Sone Michihiko, Ando Yuichi, Akiyama Masashi, Ishigami Masatoshi, Kawashima Hiroki

INVESTIGATIONAL NEW DRUGS   Vol. 41 ( 3 ) page： 512 - 521   2023.6

Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma

Mizuno Kazuyuki, Imai Norihiro, Yamamoto Takafumi, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Ishigami Masatoshi, Kawashima Hiroki

CANCERS   Vol. 15 ( 10 )   2023.5

Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.

Mizuno F, Imai N, Yasuda K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Kawashima H

Internal medicine (Tokyo, Japan)     2023.5

Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases

Imai Norihiro, Ohsaki Yuki, Cheng Jinglei, Zhang Jingjing, Mizuno Fumitaka, Tanaka Taku, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi, Wake Hiroaki, Kawashima Hiroki

SCIENTIFIC REPORTS   Vol. 13 ( 1 ) page： 6851   2023.4

Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet

Muto Hisanori, Honda Takashi, Tanaka Taku, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Maeda Keiko, Ishikawa Tetsuya, Adachi Shungo, Sato Chikara, Tsuji Noriko M., Ishigami Masatoshi, Fujishiro Mitsuhiro, Kawashima Hiroki

NUTRIENTS   Vol. 15 ( 6 )   2023.3

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Yamamoto Takafumi, Morooka Hikaru, Ito Takanori, Ishigami Masatoshi, Mizuno Kazuyuki, Yokoyama Shinya, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Yokota Kenji, Hase Tetsunari, Maeda Osamu, Hashimoto Naozumi, Ando Yuichi, Akiyama Masashi, Kawashima Hiroki

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 38 ( 2 ) page： 251 - 258   2023.2

Endoscopic injection sclerotherapy with polidocanol for cardiac varices in children and adolescents

Yokoyama Shinya, Ishizu Yoji, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Hinoki Akinari, Sumida Wataru, Shirota Chiyoe, Tainaka Takahisa, Makita Satoshi, Yokota Kazuki, Uchida Hiroo, Ishigami Masatoshi

ARCHIVES DE PEDIATRIE   Vol. 30 ( 2 ) page： 109 - 112   2023.2

The presence of high-risk varices after sclerotherapy in biliary atresia

Yokoyama Shinya, Ishizu Yoji, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Shirota Chiyoe, Tainaka Takahisa, Sumida Wataru, Makita Satoshi, Takimoto Aitaro, Nakagawa Yoichi, Takada Shunya, Ishigami Masatoshi, Uchida Hiroo, Kawashima Hiroki

PEDIATRICS INTERNATIONAL   Vol. 65 ( 1 ) page： e15454   2023.1

Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma

Inukai Yosuke, Yamamoto Kenta, Honda Takashi, Ito Takanori, Imai Norihiro, Ishizu Yoji, Nakamura Masanao, Kawashima Hiroki, Ishigami Masatoshi

DIGESTIVE DISEASES   Vol. 41 ( 1 ) page： 138 - 147   2023.1

Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet

Zhao Meng, Ma Lingyun, Honda Takashi, Kato Asuka, Ohshiro Taichi, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Nakamura Masanao, Kawashima Hiroki, Tsuji Noriko M., Ishigami Masatoshi, Fujishiro Mitsuhiro

DIGESTIVE DISEASES AND SCIENCES   Vol. 68 ( 1 ) page： 155 - 163   2023.1

Assessing the Complicated Venous Hemodynamics and Therapeutic Outcomes of Budd-Chiari Syndrome with Respiratory-gated 4D Flow MR Imaging During the Expiratory and Inspiratory Phases

Hyodo Ryota, Takehara Yasuo, Mizuno Takashi, Ichikawa Kazushige, Yokoyama Shinya, Ishizu Yoji, Naganawa Shinji

MAGNETIC RESONANCE IN MEDICAL SCIENCES   Vol. 22 ( 1 ) page： 1 - 6   2023

A Successful Living Donor Liver Transplantation Using Hepatic Iron Deposition Graft Suspected by Magnetic Resonance Imaging.

Kurata N, Shizuku M, Jobara K, Ishizu Y, Ishigami M, Ogura Y

Case reports in transplantation   Vol. 2023   page： 9075184   2023

Biochemical markers to predict the development of gastrointestinal bleeding and esophageal varices after portoenterostomy in biliary atresia

Sumida Wataru, Tainaka Takahisa, Shirota Chiyoe, Yokota Kazuki, Makita Satoshi, Okamoto Masamune, Takimoto Aitaro, Yasui Akihiro, Takada Shunya, Nakagawa Yoichi, Kato Daiki, Yokoyama Shinya, Ishizu Yoji, Amano Hizuru, Guo Yaohui, Hinoki Akinari, Uchida Hiroo

PEDIATRIC SURGERY INTERNATIONAL   Vol. 38 ( 12 ) page： 1799 - 1805   2022.12

Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease

Ozawa Naoki, Sato Kazuki, Sugimura Ayumi, Maki Shigeyoshi, Tanaka Taku, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro, Ishikawa Tetsuya, Ando Shoko

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 84 ( 4 ) page： 857 - 864   2022.11

An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images

Sugiyama Yoshiaki, Ishizu Yoji, Ando Yusuke, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Nakamura Masanao, Honda Takashi, Kawashima Hiroki, Ishikawa Tetsuya, Ishigami Masatoshi

HEPATOLOGY RESEARCH   Vol. 52 ( 11 ) page： 937 - 946   2022.11

ANOREXIA IS ASSOCIATED WITH THE PRESENCE OF SARCOPENIA IN PATIENTS WITH CIRRHOSIS

Ishizu Yoji, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Honda Takashi Honda, Ishigami Masatoshi, Kawashima Hiroki

HEPATOLOGY   Vol. 76   page： S1181 - S1181   2022.10

USEFULNESS OF MUTATIONS INDUCED IN THE CORE REGION BY INTERFERON-BASED THERAPY

Honda Takashi Honda, Ishigami Masatoshi, Kato Asuka, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Ishikawa Tetsuya, Kawashima Hiroki

HEPATOLOGY   Vol. 76   page： S262 - S263   2022.10

CLINICAL COURSE AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEMOPHILIA

Imai Norihiro, Ishigami Masatoshi, Matsuda Noritaka, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi Honda, Kawashima Hiroki

HEPATOLOGY   Vol. 76   page： S1330 - S1330   2022.10

Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study

Yamamoto Takafumi, Imai Norihiro, Kuzuya Teiji, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   Vol. 74 ( 9 ) page： 3118 - 3127   2022.8

Eosinophilic granulomatosis with polyangiitis complicated with idiopathic thrombocytopenic purpura and sclerosing cholangitis showing eosinophilic infiltration

Yamashita Yuta, Takeichi Takuya, Ishizu Yoji, Suzuki Nobuaki, Tsuboi Takashi, Matsuura Kentaro, Koizumi Haruka, Muro Yoshinao, Akiyama Masashi

JOURNAL OF DERMATOLOGY   Vol. 49 ( 8 ) page： E270 - E271   2022.8

Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma

Imai Norihiro, Ishigami Masatoshi, Oie Yumi, Kumagai Motoki, Inukai Yosuke, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Kawashima Hiroki

ANTICANCER RESEARCH   Vol. 42 ( 8 ) page： 3947 - 3951   2022.8

A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis

Yamamoto Takafumi, Ito Takanori, Mizuno Kazuyuki, Shinya Yokoyama, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Kawashima Hiroki, Matsui Toshinori, Hase Tetsunari, Hashimoto Naozumi, Ishigami Masatoshi

JOURNAL OF DIGESTIVE DISEASES   Vol. 23 ( 7 ) page： 404 - 409   2022.7

Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease

Yamamoto Kenta, Ishizu Yoji, Honda Takashi, Ito Takanori, Imai Norihiro, Nakamura Masanao, Kawashima Hiroki, Kitaura Yasuyuki, Ishigami Masatoshi, Fujishiro Mitsuhiro

SCIENTIFIC REPORTS   Vol. 12 ( 1 ) page： 3674   2022.3

Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

Kawaratani Hideto, Kondo Yasuteru, Tatsumi Ryoji, Kawabe Naoto, Tanabe Norikazu, Sakamaki Akira, Okumoto Kazuo, Uchida Yoshihito, Endo Kei, Kawaguchi Takumi, Oikawa Tsunekazu, Ishizu Yoji, Hige Shuhei, Takami Taro, Terai Shuji, Ueno Yoshiyuki, Mochida Satoshi, Takikawa Yasuhiro, Torimura Takuji, Matsuura Tomokazu, Ishigami Masatoshi, Koike Kazuhiko, Yoshiji Hitoshi

JOURNAL OF CLINICAL MEDICINE   Vol. 11 ( 6 )   2022.3

Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Yamamoto Takafumi, Ito Takanori, Hase Tetsunari, Ishigami Masatoshi, Mizuno Kazuyuki, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Shibata Hirofumi, Hatta Takahiro, Yogo Naoyuki, Yasuda Satoshi, Toyoda Hidenori, Abe Takashi, Kawashima Hiroki, Hashimoto Naozumi, Fujishiro Mitsuhiro

CANCER INVESTIGATION   Vol. 40 ( 2 ) page： 189 - 198   2022.2

Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis

HEPATOLOGY RESEARCH   Vol. 52 ( 2 ) page： 199 - 209   2022.2

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia HCC after HCV eradication in hemophilia

Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

ANNALS OF HEPATOLOGY   Vol. 27 ( 1 ) page： 100545   2022

Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosis

Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Yokoyama Shinya, Ishikawa Tetsuya, Kawashima Hiroki

NUTRITION   Vol. 103   page： 111807   2022

Factors associated with the progression of myosteatosis in patients with cirrhosis

Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Yokoyama Shinya, Ishikawa Tetsuya, Fujishiro Mitsuhiro

NUTRITION   Vol. 103   page： 111777   2022

Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic Obliteration

Yokoyama Shinya, Ishizu Yoji, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Komada Tomohiro, Hayashi Masamichi, Ishigami Masatoshi

INTERNAL MEDICINE   Vol. 61 ( 23 ) page： 3503 - 3511   2022

Changes in the gut microbiota after hepatitis C virus eradication

Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Takeyama Tomoaki, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Nakamura Masanao, Kawashima Hiroki, Miyahara Ryoji, Ishikawa Tetsuya, Hirooka Yoshiki, Fujishiro Mitsuhiro

SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page： 23568   2021.12

Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis. Reviewed

Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M

European journal of gastroenterology & hepatology   Vol. 33 ( 1S Suppl 1 ) page： e916 - e921   2021.12

Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine

Yamamoto Kenta, Honda Takashi, Yokoyama Shinya, Ma Lingyun, Kato Asuka, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Nakamura Masanao, Kawashima Hiroki, Ishigami Masatoshi, Tsuji Noriko M., Fujishiro Mitsuhiro

DIGESTIVE AND LIVER DISEASE   Vol. 53 ( 11 ) page： 1443 - 1450   2021.11

Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes

Imai Norihiro, Yokoyama Shinya, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi

ANTICANCER RESEARCH   Vol. 41 ( 11 ) page： 5817 - 5820   2021.11

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Ito Takanori, Ishigami Masatoshi, Yamamoto Takafumi, Mizuno Kazuyuki, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Kawashima Hiroki, Yasuda Satoshi, Toyoda Hidenori, Yokota Kenji, Hase Tetsunari, Nishio Naoki, Maeda Osamu, Kato Masashi, Hashimoto Naozumi, Hibi Hideharu, Kodera Yasuhiro, Sone Michihiko, Ando Yuichi, Akiyama Masashi, Shimoyama Yoshie, Fujishiro Mitsuhiro

HEPATOLOGY INTERNATIONAL   Vol. 15 ( 5 ) page： 1278 - 1287   2021.10

Factors associated with bleeding after endoscopic variceal ligation in children

Yokoyama Shinya, Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ito Takanori, Hinoki Akinari, Sumida Wataru, Shirota Chiyoe, Tainaka Takahisa, Makita Satoshi, Yokota Kazuki, Uchida Hiroo, Fujishiro Mitsuhiro

PEDIATRICS INTERNATIONAL   Vol. 63 ( 10 ) page： 1223 - 1229   2021.10

USEFULNESS OF CORE I97L IN PREDICTING THE EFFICACY OF NUCLEOS(T)IDE ANALOGUE THERAPY IN PATIENTS WITH HEPATITIS B

TakashiHonda, MasatoshiIshigami, ShinyaYokoyama, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Ishikawa Tetsuya, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 74   page： 468A - 469A   2021.10

A PROPOSAL FOR AN APPROPRIATE METHOD OF ASSESSING FUNCTIONAL SKELETAL MUSCLE MASS USING COMPUTED TOMOGRAPHY IN PATIENTS WITH LIVER CIRRHOSIS

Sugiyama Yoshiaki, Ishizu Yoji, Ishigami Masatoshi

HEPATOLOGY   Vol. 74   page： 1203A - 1203A   2021.10

Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis

Muto Hisanori, Ito Takanori, Tanaka Taku, Yokoyama Shinya, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Maeda Keiko, Honda Takashi, Ishikawa Tetsuya, Kato Asuka, Ohshiro Taichi, Kano Fumiya, Yamamoto Akihito, Sakai Kiyoshi, Hibi Hideharu, Ishigami Masatoshi, Fujishiro Mitsuhiro

SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page： 18778   2021.9

Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications

Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Kamei Hideya, Ogura Yasuhiro, Fujishiro Mitsuhiro

EXPERIMENTAL AND CLINICAL TRANSPLANTATION   Vol. 19 ( 9 ) page： 935 - 942   2021.9

Transient deterioration of albumin-bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation A STROBE-compliant retrospective observational study

Muto Hisanori, Kuzuya Teiji, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Ishigami Masatoshi, Fujishiro Mitsuhiro

MEDICINE   Vol. 100 ( 31 ) page： e26820   2021.8

Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty

Ozawa Naoki, Sato Kazuki, Sugimura Ayumi, Maki Shigeyoshi, Tanaka Taku, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro, Ishikawa Tetsuya, Ando Shoko

JAPAN JOURNAL OF NURSING SCIENCE   Vol. 18 ( 3 ) page： e12415   2021.7

The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs

Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi

JOURNAL OF HEPATOLOGY   Vol. 75   page： S787 - S788   2021.7

Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs

Yamamoto Takafumi, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

ANTICANCER RESEARCH   Vol. 41 ( 5 ) page： 2569 - 2573   2021.5

Impact of visceral fat accumulation on the prognosis of patients with cirrhosis Reviewed

Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Fujishiro Mitsuhiro

CLINICAL NUTRITION ESPEN   Vol. 42   page： 354 - 360   2021.4

Time-resolved 3D cine phase-contrast magnetic resonance imaging (4D-flow MRI) can quantitatively assess portosystemic shunt severity and confirm normalization of portal flow after embolization of large portosystemic shunts Reviewed

Hyodo Ryota, Takehara Yasuo, Mizuno Takashi, Ichikawa Kazushige, Ishizu Yoji, Sugiyama Masataka, Naganawa Shinji

HEPATOLOGY RESEARCH   Vol. 51 ( 3 ) page： 343 - 349   2021.3

The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C Reviewed

Yamamoto Kenta, Honda Takashi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Nakamura Masanao, Miyahara Ryoji, Kawashima Hiroki, Ishigami Masatoshi, Fujishiro Mitsuhiro

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 36 ( 3 ) page： 790 - 799   2021.3

Simplification of balloon-occluded retrograde transcatheter obliteration procedure using a coaxial double balloon catheter compared with a single-balloon catheter Reviewed

Ishizu Yoji, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ito Takanori, Komada Tomohiro, Fujishiro Mitsuhiro

JAPANESE JOURNAL OF RADIOLOGY   Vol. 39 ( 3 ) page： 296 - 302   2021.3

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia Reviewed

Yamamoto Takafumi, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

HAEMOPHILIA   Vol. 27 ( 1 ) page： 100 - 107   2021.1

Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma

Matsuda Noritaka, Imai Norihiro, Kuzuya Teiji, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

IN VIVO   Vol. 35 ( 2 ) page： 1185 - 1189   2021

Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure

Honda Takashi, Yamada Norie, Murayama Asako, Shiina Masaaki, Aly Hussein Hassan, Kato Asuka, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Ishigami Masatoshi, Murakami Yoshiki, Tanaka Tomohisa, Moriishi Kohji, Nishitsuji Hironori, Shimotohno Kunitada, Ishikawa Tetsuya, Fujishiro Mitsuhiro, Muramatsu Masamichi, Wakita Takaji, Kato Takanobu

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY   Vol. 12 ( 5 ) page： 1583 - 1598   2021

AMINO ACID POLYMORPHISM IN HEPATITIS B VIRUS ASSOCIATED WITH NATURAL CLEARANCE OF HBV DNA AND HBsAg

Honda Takashi, Yamada None, Murayama Asako, Kato Asuka, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Ishigami Masatoshi, Murakami Yoshiki, Ishikawa Tetsuya, Fujishiro Mitsuhiro, Kato Takanobu

HEPATOLOGY   Vol. 72   page： 508A - 509A   2020.11

IMPROVEMENT OF LIVER FUNCTIONAL RESERVE AFTER SVR IN HCV-PATIENTS WITH COMPENSATED, SEVERE FIBROSIS BY IFN-FREE, DAA COMBINATION TREATMENT-IMPACT OF PRETREATMENT SERUM AFP LEVELS

Ishigami Masatoshi, Honda Takashi, Ishizu Yoji, Imai Norihiro, Ito Takanori, Yamamoto Kenta, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 72   page： 564A - 565A   2020.11

GUT MICROBIOTA ASSOCIATED WITH THE DIFFERENCE BETWEEN PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA IN CHRONIC LIVER DISEASE

Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Imai Norihiro, Ishizu Yoji, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 72   page： 370A - 370A   2020.11

The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC Reviewed

Ito Takanori, Ishigami Masatoshi, Morooka Hikaru, Yamamoto Kenta, Imai Norihiro, Ishizu Yoji, Honda Takashi, Nishimura Daisaku, Tada Toshifumi, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

SCIENTIFIC REPORTS   Vol. 10 ( 1 ) page： 17812   2020.10

Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion. Reviewed

Tanaka T, Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Ishikawa T, Fujishiro M

Oncology   Vol. 98 ( 9 ) page： 621 - 629   2020.9

Revisiting the indications for liver transplantation in cirrhotic patients considering the long-term outcomes of cirrhotic patients

Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Kamei Hideya, Ogura Yasuhiro, Fujishiro Mitsuhiro

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   Vol. 27 ( 9 ) page： 655 - 662   2020.9

Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival. Reviewed

Nomura A, Ishigami M, Honda T, Kuzuya T, Ishizu Y, Ito T, Kamei H, Onishi Y, Ogura Y, Fujishiro M

Medicine   Vol. 99 ( 28 ) page： e21161   2020.7

Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease Reviewed

Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   Vol. 72 ( 5 ) page： 884 - 891   2020.7

Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease Reviewed

Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY   Vol. 32 ( 6 ) page： 748 - 753   2020.6

Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report Reviewed

Muto Hisanori, Kuzuya Teiji, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Ishigami Masatoshi, Fujishiro Mitsuhiro

CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 13 ( 3 ) page： 397 - 402   2020.6

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies Reviewed

Mizuno Kazuyuki, Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Kawashima Hiroki, Inukai Yosuke, Toyoda Hidenori, Yokota Kenji, Hase Tetsunari, Maeda Osamu, Kiyoi Hitoshi, Nagino Masato, Hibi Hideharu, Kodera Yasuhiro, Fujimoto Yasushi, Sone Michihiko, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Fujishiro Mitsuhiro

JOURNAL OF GASTROENTEROLOGY   Vol. 55 ( 6 ) page： 653 - 661   2020.6

Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma

Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro

ANTICANCER RESEARCH   Vol. 40 ( 4 ) page： 2089 - 2093   2020.4

Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Reviewed

Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro

ANTICANCER RESEARCH   Vol. 40 ( 4 ) page： 2283 - 2290   2020.4

Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma Reviewed

Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro

HEPATOLOGY RESEARCH   Vol. 50 ( 3 ) page： 374 - 381   2020.3

Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib

Yamamoto Kenta, Kuzuya Teiji, Honda Takashi, Ito Takanori, Ishizu Yoji, Nakamura Masanao, Miyahara Ryoji, Kawashima Hiroki, Ishigami Masatoshi, Fujishiro Mitsuhiro

ANTICANCER RESEARCH   Vol. 40 ( 2 ) page： 665 - 676   2020.2

Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. Reviewed

Yoshioka N, Ishigami M, Watanabe Y, Sumi H, Doisaki M, Yamaguchi T, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Haruta JI, Fujishiro M

Scientific reports   Vol. 10 ( 1 ) page： 481   2020.1

Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection Reviewed

Ishizu Yoji, Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ito Takanori, Fujishiro Mitsuhiro

HEPATOLOGY RESEARCH   Vol. 50 ( 1 ) page： 47 - 56   2020.1

Sarcopenia impairs health-related quality of life in cirrhotic patients

Ando Yusuke, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Fujishiro Mitsuhiro

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY   Vol. 31 ( 12 ) page： 1550 - 1556   2019.12

CHANGES OF MICROBIOTA AFTER HEPATITIS C VIRUS ERADICATION

Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 70   page： 1160A - 1161A   2019.10

INDICATION FOR HCC TREATMENT IN RECENT ERA-PROPOSAL OF THE NEW PRIORITY FOR LIVER TRANSPLANTATION IN PATIENTS WITH HCC

Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 70   page： 543A - 544A   2019.10

Feasibility and usefulness of endoscopic ultrasonography-guided shear-wave measurement for assessment of autoimmune pancreatitis activity: a prospective exploratory study

Ohno Eizaburo, Hirooka Yoshiki, Kawashima Hiroki, Ishikawa Takuya, Tanaka Hiroyuki, Sakai Daisuke, Ishizu Yoji, Kuzuya Teiji, Nakamura Masanao, Honda Takashi

JOURNAL OF MEDICAL ULTRASONICS   Vol. 46 ( 4 ) page： 425 - 433   2019.10

NON-INVASIVE SCREENING FOR DETECTING ESOPHAGOGASTRIC VARICES IN CHILDREN WITH BILIARY ATRESIA

Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Shirota Chiyoe, Uchida Hiroo, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 70   page： 200A - 200A   2019.10

UTILITY OF THE ALBUMIN-BILIRUBIN SCORE FOR PREDICTING PROGNOSIS IN JAPANESE PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: AN ANALYSIS USING TIME-DEPENDENT RECEIVER OPERATING CHARACTERISTICS

Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Yasuda Satoshi, Toyoda Hidenori, Kumada Takashi, Fujishiro Mitsuhiro

HEPATOLOGY   Vol. 70   page： 789A - 790A   2019.10

Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia

Yokoyama Shinya, Ishigami Masatoshi, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ito Takanori, Hirooka Yoshiki, Tanaka Yujiro, Tainaka Takahisa, Shirota Chiyoe, Chiba Kosuke, Uchida Hiroo, Fujishiro Mitsuhiro

HEPATOLOGY RESEARCH   Vol. 49 ( 10 ) page： 1162 - 1168   2019.10

Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment

Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Hirooka Yoshiki, Fujishiro Mitsuhiro

HEPATOLOGY RESEARCH   Vol. 49 ( 9 ) page： 1054 - 1065   2019.9

Antifibrotic Effects of 1,25(OH)(2)D-3 on Nonalcoholic Steatohepatitis in Female Mice

Ma Lingyun, Ishigami Masatoshi, Honda Takashi, Yokoyama Shinya, Yamamoto Kenta, Ishizu Yoji, Kuzuya Teiji, Hayashi Kazuhiko, Hirooka Yoshiki, Goto Hidemi

DIGESTIVE DISEASES AND SCIENCES   Vol. 64 ( 9 ) page： 2581 - 2590   2019.9

The relationship between portal hypertension and the microbiome

Yamamoto K., Honda T., Hattori S., Pu L. Zorron Cheng Tao, Ito T., Yamamura T., Ishizu Y., Kuzuya T., Ishigami M., Fujishiro M.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 34   page： 106 - 107   2019.9

Association between core mutations and annual decline rate of HBVDNA and HBsAg in chronic hepatitis B patients treated with nucleoside analogue

Honda Takashi, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro

JOURNAL OF HEPATOLOGY   Vol. 70 ( 1 ) page： E258 - E258   2019.4

Association between gut microbiota and hepatocellular carcinoma in patients with chronic liver disease

Honda Takashi, Ishigami Masatoshi, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Fujishiro Mitsuhiro

JOURNAL OF HEPATOLOGY   Vol. 70 ( 1 ) page： E512 - E513   2019.4

Serum Zinc levels as a prognostic factor for extra-hepatic carcinogenesis in Japanese patients with non-alcoholic liver disease

Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro

JOURNAL OF HEPATOLOGY   Vol. 70 ( 1 ) page： E298 - E298   2019.4

The optimal cut-off points of FIB-4 index for predicting the incidences of HCC and extra-hepatic malignancies in biopsyproven Japanese NAFLD patients

Ito Takanori, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Fujishiro Mitsuhiro

JOURNAL OF HEPATOLOGY   Vol. 70 ( 1 ) page： E775 - E775   2019.4

The early clinical response at 2 weeks of lenvatinib therapy for patients with advanced HCC

Kuzuya Teiji, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Honda Takashi, Fujishiro Mitsuhiro

JOURNAL OF HEPATOLOGY   Vol. 70 ( 1 ) page： E611 - E611   2019.4

Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report

Kuzuya Teiji, Ishigami Masatoshi, Ishizu Yoji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Hirooka Yoshiki, Goto Hidemi

HEPATOLOGY RESEARCH   Vol. 49 ( 3 ) page： 360 - 364   2019.3

Influence of proton pump inhibitors on microbiota in chronic liver disease patients

Yamamoto Kenta, Ishigami Masatoshi, Honda Takashi, Takeyama Tomoaki, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Hayashi Kazuhiko, Goto Hidemi, Hirooka Yoshiki

HEPATOLOGY INTERNATIONAL   Vol. 13 ( 2 ) page： 234 - 244   2019.3

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Nishimura D, Toyoda H, Kumada T, Goto H, Hirooka Y

Journal of gastroenterology and hepatology   Vol. 34 ( 1 ) page： 207-214   2019.1

Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity

Yoshioka Naoki, Kuzuya Teiji, Ito Takanori, Ishizu Yoji, Honda Takashi, Ishikawa Tetsuya, Ishigami Masatoshi, Fujishiro Mitsuhiro

INTERNAL MEDICINE   Vol. 58 ( 19 ) page： 2803 - 2808   2019

The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy

Hayashi Kazuhiko, Tachi Kosuke, Shimizu Yuko, Nagano Kenichi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Hirooka Yoshiki, Hattori Masashi, Goto Hidemi

INTERVIROLOGY   Vol. 62 ( 1 ) page： 23 - 29   2019

Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma

Ando Yusuke, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki

CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 11 ( 6 ) page： 514 - 520   2018.12

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy

Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki, Toyoda Hidenori, Kumada Takashi, Hattori Masashi, Katano Yoshiaki, Goto Hidemi

JOURNAL OF VIRAL HEPATITIS   Vol. 25 ( 12 ) page： 1446 - 1451   2018.12

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication

Yasuda Satoshi, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Toyoda Hidenori, Kumada Takashi, Hirooka Yoshiki, Goto Hidemi

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 33 ( 11 ) page： 1904 - 1911   2018.11

Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease

Tachi Yoshihiko, Kozuka Akihiro, Hirai Takanori, Kojima Yuko, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi

NUTRITION   Vol. 54   page： 83 - 88   2018.10

Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients

Honda Takashi, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Hirooka Yoshiki

HEPATOLOGY   Vol. 68   page： 1233A-1234A   2018.10

Late Relapse and Molecular Analysis of Hepatitis C Virus in Patients with Sustained Virological Response By All Oral Direct Acting Antivirals Therapy

Hayashi Kazuhiko, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishigami Masatoshi, Shimizu Yuko, Tachi Kousuke, Goto Hidemi

HEPATOLOGY   Vol. 68   page： 927A-927A   2018.10

Interferon-Free Antiviral Therapy Rapidly Improves Thrombocytopenia in Patients with Advanced Chronic Hepatitis C

Ishizu Yoji, Ishigami Masatoshi, Ito Takanori, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki

HEPATOLOGY   Vol. 68   page： 1157A-1158A   2018.10

Comparison of Gut Microbiota and Predicted Functional Metagenome in Hepatitis C Patients with and without Advanced Fibrosis Categorized By FIB4-Index

Yamamoto Kenta, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki

HEPATOLOGY   Vol. 68   page： 590A-590A   2018.10

Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response

Tachi Yoshihiko, Hirai Takanori, Kojima Yuko, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi, Katano Yoshiaki

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY   Vol. 30 ( 9 ) page： 1066 - 1072   2018.9

Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease

Tachi Yoshihiko, Kozuka Akihiro, Hirai Takanori, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 33 ( 9 ) page： 1659 - 1666   2018.9

Successful treatment of esophageal bleeding due to rupture of major aortopulmonary collateral arteries by transcatheter arterial embolization.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Matsushima M, Kato T, Hirooka Y

Clinical journal of gastroenterology     2018.8

Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus

Imai H., Kamei H., Onishi Y., Ishizu Y., Ishigami M., Goto H., Ogura Y.

TRANSPLANTATION PROCEEDINGS   Vol. 50 ( 5 ) page： 1431 - 1436   2018.6

Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93

Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Hirooka Yoshiki, Goto Hidemi

JOURNAL OF MEDICAL VIROLOGY   Vol. 90 ( 4 ) page： 736 - 744   2018.4

Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy

Hayashi K., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hirooka Y., Goto H.

JOURNAL OF HEPATOLOGY   Vol. 68   page： S297-S297   2018.4

Utility and limitation of non-invasive fibrosis markers for predicting the prognosis in biopsy-proven Japanese NAFLD patients

Ito T., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.

JOURNAL OF HEPATOLOGY   Vol. 68   page： S561-S561   2018.4

Secreted ectodomain of SIGLEC-9 and MCP-1 ameliorate acute liver failure in rats by altering bone marrow macrophage polarity

Ito T., Ishigami M., Yamamoto A., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.

JOURNAL OF HEPATOLOGY   Vol. 68   page： S614-S614   2018.4

Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment

Ando Yusuke, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Nakano Isao, Hirooka Yoshiki, Goto Hidemi

HEPATOLOGY RESEARCH   Vol. 48 ( 3 ) page： E240 - E251   2018.2

Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy

Hayashi Kazuhiko, Ishigami Masatoshi, Yasuda Satoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Ishikawa Tetsuya, Hirooka Yoshiki, Goto Hidemi

HEPATOLOGY RESEARCH   Vol. 48 ( 3 ) page： E78 - E86   2018.2

Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b

Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Kawashima Hiroki, Ishikawa Tetsuya, Tachi Yoshihiko, Hattori Masashi, Katano Yoshiaki, Goto Hidemi, Hirooka Yoshiki

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 33 ( 1 ) page： 249 - 255   2018.1

Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response

Tachi Yoshihiko, Hirai Takanori, Kojima Yuko, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi

LIVER INTERNATIONAL   Vol. 38 ( 1 ) page： 59 - 67   2018.1

Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment

Kuzuya Teiji, Ishigami Masatoshi, Ishizu Yoji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Nakano Isao, Hirooka Yoshiki, Goto Hidemi

ONCOLOGY   Vol. 95 ( 2 ) page： 91 - 99   2018

Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data

Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 32 ( 11 ) page： 1879 - 1886   2017.11

Low skeletal muscle mass predicts early mortality in cirrhotic patients with acute variceal bleeding

Ishizu Yoji, Ishigami Masatoshi, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Hirooka Yoshiki, Goto Hidemi

NUTRITION   Vol. 42   page： 87 - 91   2017.10

Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model

Imai Norihiro, Suzuki Michitaka, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Ishigami Masatoshi, Hirooka Yoshiki, Ishikawa Tetsuya, Goto Hidemi, Fujimoto Toyoshi

HISTOCHEMISTRY AND CELL BIOLOGY   Vol. 148 ( 3 ) page： 219 - 227   2017.9

Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct-acting antivirals

Tachi Yoshihiko, Hirai Takanori, Kojima Yuko, Ishizu Yoji, Honda Takashi, Kuzuya Teiji, Hayashi Kazuhiko, Ishigami Masatoshi, Goto Hidemi

JGH OPEN   Vol. 1 ( 1 ) page： 44 - 49   2017.9

Utility of Doppler ultrasonography for diagnosing and assessing treatment effects in liver compartment syndrome

Ando Yusuke, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hayashi Kazuhiko, Ishikawa Tetsuya, Goto Hidemi, Hirooka Yoshiki

CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 10 ( 3 ) page： 265 - 269   2017.6

Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B

Honda T., Ishigami M., Ishizu Y., Kuzuya T., Hayashi K., Ishikawa T., Murakami Y., Iwadate M., Umeyama H., Toyoda H., Kumada T., Katano Y., Goto H., Hirooka Y.

CLINICAL MICROBIOLOGY AND INFECTION   Vol. 23 ( 6 ) page： 407.e1 - 407.e7   2017.6

Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction

Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY   Vol. 15 ( 5 ) page： 787 - 788   2017.5

Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice

Honda Takashi, Ishigami Masatoshi, Luo Fangqiong, Lingyun Ma, Ishizu Yoji, Kuzuya Teiji, Hayashi Kazuhiko, Nakano Isao, Ishikawa Tetsuya, Feng Guo-Gang, Katano Yoshiaki, Kohama Tomoya, Kitaura Yasuyuki, Shimomura Yoshiharu, Goto Hidemi, Hirooka Yoshiki

METABOLISM-CLINICAL AND EXPERIMENTAL   Vol. 69   page： 177 - 187   2017.4

Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: A case report Reviewed

Yoji Ishizu, Masatoshi Ishigami, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Isao Nakano, Yoshiki Hirooka, Hidemi Goto

Hepatology Research   Vol. 46 ( 6 ) page： 601-606   2015.10

Endoscopic treatment of esophageal varices in hemophiliac patients with liver cirrhosis. Reviewed

Ishizu Y, Ishigami M, Suzuki N, Kuzuya T, Honda T, Hayashi K, Katano Y, Hirooka Y, Ishikawa T, Matsushita T, Goto H.

Gastrointest Endosc.   Vol. 81 ( 4 ) page： 1059-60   2015.4

Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C Reviewed

Ishizu Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.

J Gastroenterol Hepatol.   Vol. 27 ( 6 ) page： 1112-6   2012.6